Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
HUMANIGEN, INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
HUMANIGEN, INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
HUMANIGEN, INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
HUMANIGEN, INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
HUMANIGEN, INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
HUMANIGEN, INCListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Radius Health, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Sell | $283.5K | SEC | ||
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Sell | $239.2K | SEC | ||
EPIRUS Biopharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Pharmasset IncListing on record | Sell | $401.7K | SEC | ||
Pharmasset IncListing on record | Sell | $146.8K | SEC | ||
ReShape Weightloss Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
ReShape Weightloss Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
ReShape Weightloss Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ReShape Weightloss Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ReShape Weightloss Inc.Listing unverified | Buy | $5M | conv 38Cluster | SEC | |
ReShape Weightloss Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ReShape Weightloss Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
ARYx Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC | ||
ARYx Therapeutics, Inc.Security delisted | Buy | $3M | conv 53ClusterFirst in 12mo | SEC | |
ARYx Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ARYx Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC | ||
ARYx Therapeutics, Inc.Security delisted | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ARYx Therapeutics, Inc.Security delisted | Other | n/a (No price was disclosed in the filing) | SEC |